AMNEAL PHARMACEUTICALS, INC. Effective Tax Rate
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Effective Tax Rate of 1.90% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-08-06
- AMNEAL PHARMACEUTICALS, INC. effective income tax rate reconciliation, percent for the quarter ending 2026-06-30 was 1.90%, a 93.89% decline year-over-year.
- AMNEAL PHARMACEUTICALS, INC. effective income tax rate reconciliation, percent for the quarter ending 2026-03-31 was 2.70%, a 92.13% decline year-over-year.
- AMNEAL PHARMACEUTICALS, INC. effective income tax rate reconciliation, percent for the quarter ending 2025-09-30 was 447.20%, a 1778.99% increase year-over-year.
- AMNEAL PHARMACEUTICALS, INC. effective income tax rate reconciliation, percent for the quarter ending 2025-06-30 was 31.10%, a 75.71% increase year-over-year.
- AMNEAL PHARMACEUTICALS, INC. effective income tax rate reconciliation, percent for fiscal 2025 was 8.10%.
- AMNEAL PHARMACEUTICALS, INC. effective income tax rate reconciliation, percent for fiscal 2024 was -34.30%.
- AMNEAL PHARMACEUTICALS, INC. effective income tax rate reconciliation, percent for fiscal 2023 was -21.00%.
- AMNEAL PHARMACEUTICALS, INC. effective income tax rate reconciliation, percent for fiscal 2022 was -2.70%, a 107.56% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 3 month as first filed | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 6 month as first filed | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | 1.90% 10-Q · filed 2026-08-06 | 2.30% 10-Q · filed 2026-08-06 | ||||
| 2026-03-31 | 2.70% 10-Q · filed 2026-05-07 | |||||
| 2025-12-31 | 8.10% 10-K · filed 2026-02-27 | |||||
| 2025-09-30 | 447.20% 10-Q · filed 2025-11-06 | 6.70% 10-Q · filed 2025-11-06 | ||||
| 2025-06-30 | 31.10% 10-Q · filed 2026-08-06 | 32.50% 10-Q · filed 2026-08-06 | ||||
| 2025-03-31 | 34.30% 10-Q · filed 2026-05-07 | |||||
| 2024-12-31 | -34.30% 10-K · filed 2026-02-27 | |||||
| 2024-09-30 | 23.80% 10-Q · filed 2025-11-06 | -33.90% 10-Q · filed 2025-11-06 | ||||
| 2024-06-30 | 17.70% 10-Q · filed 2025-08-07 | -17.70% 10-Q · filed 2025-08-07 | ||||
| 2024-03-31 | -8.20% 10-Q · filed 2025-05-07 | |||||
| 2023-12-31 | -21.00% 10-K · filed 2026-02-27 | |||||
| 2023-09-30 | -9.00% 10-Q · filed 2024-11-12 | -3.30% 10-Q · filed 2024-11-12 | ||||
| 2023-06-30 | 3.20% 10-Q · filed 2024-08-09 | |||||
| 2023-03-31 | -7.10% 10-Q · filed 2024-05-08 | |||||
| 2022-12-31 | -2.70% 10-K · filed 2025-02-28 | |||||
| 2022-09-30 | 209.60% 10-Q · filed 2023-11-09 | -3.50% 10-Q · filed 2023-11-09 | ||||
| 2022-06-30 | -3.20% 10-Q · filed 2023-08-08 | -1.60% 10-Q · filed 2023-08-08 | ||||
| 2022-03-31 | 34.90% 10-Q · filed 2023-05-09 | |||||
| 2021-12-31 | 35.70% 10-K · filed 2024-03-14 | |||||
| 2021-09-30 | -198.20% 10-Q · filed 2022-11-07 | 14.80% 10-Q · filed 2022-11-07 | ||||
| 2021-06-30 | 7.60% 10-Q · filed 2022-08-08 | 6.00% 10-Q · filed 2022-08-08 | ||||
| 2021-03-31 | 2.40% 10-Q · filed 2022-05-06 | |||||
| 2020-12-31 | 291.70% 10-K · filed 2023-03-03 | |||||
| 2020-09-30 | -0.70% 10-Q · filed 2021-11-08 | 349.30% 10-Q · filed 2021-11-08 | ||||
| 2020-06-30 | -10.00% 10-Q · filed 2021-08-09 | 1259.70% 10-Q · filed 2021-08-09 | ||||
| 2020-03-31 | -810.60% 10-Q · filed 2021-05-07 | 810.60% 10-Q · filed 2020-05-11 | ||||
| 2019-12-31 | -174.00% 10-K · filed 2022-03-01 | |||||
| 2019-09-30 | 1483.00% 10-Q · filed 2020-11-06 | -230.20% 10-Q · filed 2020-11-06 | ||||
| 2019-06-30 | 10.10% 10-Q · filed 2020-08-06 | 7.50% 10-Q · filed 2020-08-06 | ||||
| 2019-03-31 | 6.30% 10-Q · filed 2020-05-11 | |||||
| 2018-12-31 | 0.70% 10-K · filed 2021-03-01 | |||||
| 2018-09-30 | 22.60% 10-Q · filed 2019-11-07 | 3.70% 10-Q · filed 2019-11-07 | ||||
| 2018-06-30 | 4.70% 10-Q · filed 2019-08-05 | -4.70% 10-Q · filed 2018-08-09 | 5.70% 10-Q · filed 2019-08-05 | -5.70% 10-Q · filed 2018-08-09 | ||
| 2018-03-31 | 0.70% 10-Q · filed 2019-05-09 | |||||
| 2017-12-31 | 1.20% 10-K · filed 2020-03-02 | |||||
| 2017-09-30 | 2.80% 10-Q · filed 2018-11-07 | 1.90% 10-Q · filed 2018-11-07 | ||||
| 2017-06-30 | 4.70% 10-Q · filed 2018-08-09 | 3.40% 10-Q · filed 2018-08-09 | ||||
| 2016-12-31 | 2.50% 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |